Controversies in acral lentiginous melanoma

Dermatologic Surgery

Volumn 28, Issue 11, 2002, Pages 1051-1059

  Stalkup, Jennifer R ^a   Orengo, Ida F ^a   Katta, Rajani ^a   Ahmed, Iftikhar ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; GANGLIOSIDE; INTERLEUKIN 2; PROTEIN P53; RECOMBINANT ALPHA INTERFERON; STEM CELL FACTOR;

ACRAL LENTIGINOUS MELANOMA; AMPUTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; EXCISION; HISTOLOGY; HISTORY; HUMAN; LIMB; LIMB PERFUSION; LITERATURE; LYMPH NODE DISSECTION; MELANOMA; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; SKIN SURGERY; SKIN TRANSPLANTATION; STANDARDIZATION; SURGICAL TECHNIQUE; TREATMENT INDICATION;

FORECASTING; HUMANS; MELANOMA; PROGNOSIS; SKIN NEOPLASMS;

EID: 0036861392     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2002.02082.x     Document Type: Article

References (0)